Solvonis Therapeutics plc (LSE: SVNS), an emerging biopharmaceutical company developing novel medicines for high-burden central nervous system (‘CNS’) disorders, is delighted to announce the appointment of Paul Carter as Non-Executive Director, effective 27 October 2025. Paul Carter is a highly accomplished global biopharmaceutical leader with nearly three decades of senior…
Metals Focus published its annual Precious Metals Investment Focus report on Saturday (October 25). The report from the leading…
TSX-V: WLR Frankfurt: 6YL Walker Lane Resources Ltd. (TSXV: WLR,OTC:CMCXF) (Frankfurt: 6YL); ‘Walker Lane’) is pleased to announce that…
Astral Resources (AAR:AU) has announced Key Appointments to Advance Mandilla Gold Project Download the PDF here. This post appeared…
Altech Batteries (ATC:AU) has announced Altech – SNC Batteries Outstanding Safety Destructve Testing Download the PDF here. This post…
Jangada Mines Plc (AIM: JAN), a Brazil focused natural resource development company, is pleased to announce that its 15-hole…
RemSense Technologies (REM:AU) has announced ExxonMobil Project Confirms REMs Top Tier Energy Position Download the PDF here. This post…
Tight export controls out of the Democratic Republic of Congo (DRC) added tailwinds to cobalt prices in Q3, prompting…